drugset / Trial / NCT03661775

Serum Magnesium Level Administration in Severe Pre-eclampsia Obese Pregnancy

NCT03661775

RandomizedFactorialOpen-labelPrevention

Summary

Comparison of the magnesium level in difference continuous rate in women who were diagnosed severe pre-eclampsia obese

Timeline

Start
2018-09-30
Primary completion
2018-12-30
Completion
2019-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 2 g
Subject Magnesium Sulfate Other / unclassified 2.5 g

Indications